Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
J Pharm Bioallied Sci ; 15(Suppl 2): S1069-S1071, 2023 Jul.
Article in English | MEDLINE | ID: mdl-37693998

ABSTRACT

Introduction: A variation in dental pain following tooth extraction and implant placement has been observed. The present study aimed to compare pain in patients undergoing tooth extraction and implant placement. Materials and Methods: Eighty-four patients underwent tooth extraction and implant placement in maxillary central incisor. Pain (VAS) was recorded at 24 h, 24 h, and 48 h. Results: The mean pain value (VAS) at 24 h post-operatively after tooth extraction was 6.1 and after implant insertion was 2.9. At 48 h after tooth extraction was 4.3 and after implant insertion was 1.1 and after 72 h after tooth extraction was 2.4 and after implant insertion was 0.27. A significant difference was observed between both procedures at different intervals of time (P < 0.05). Conclusion: The pain experienced by patients during dental implant insertion was comparatively less as compared to dental tooth extraction.

2.
Cytokine ; 145: 155208, 2021 09.
Article in English | MEDLINE | ID: mdl-32736961

ABSTRACT

Dendritic cells (DCs), as antigen-presenting cells, can reportedly be infected withLeishmaniaparasites and hence provide a better option to trigger T-cell primary immune responses and immunological memory. We consistently primed DCs during culture with purified recombinant cytosolic tryparedoxin (rcTXN) and then evaluated the vaccine prospect of presentation of rcTXN against VL in BALB/c mice. We reported earlier the immunogenic properties of cTXN antigen derived fromL. donovani when anti-cTXN antibody was detected in the sera of kala-azar patients. It was observed that cTXN antigen, when used as an immunogen with murine DCs acting as a vehicle, was able to induce complete protection against VL in an infected group of immunized mice. This vaccination triggered splenic macrophages to produce more IL-12 and GM-CSF, and restricted IL-10 release to a minimum in an immunized group of infected animals. Concomitant changes in T-cell responses against cTXN antigen were also noticed, which increased the release of protective cytokine-like IFN-γ under the influence of NF-κß in the indicated vaccinated group of animals. All cTXN-DCs-vaccinated BALB/c mice survived during the experimental period of 120 days. The results obtained in our study suggest that DCs primed with cTXN can be used as a vaccine prospect for the control of visceral leishmaniasis.


Subject(s)
Dendritic Cells/immunology , Leishmania donovani/immunology , Leishmaniasis Vaccines/immunology , Leishmaniasis, Visceral/immunology , Animals , Cytokines/immunology , Dendritic Cells/parasitology , Immunity, Cellular/immunology , Interleukin-10/immunology , Interleukin-12/immunology , Leishmaniasis, Visceral/parasitology , Macrophages/immunology , Macrophages/parasitology , Mice , Mice, Inbred BALB C , Protozoan Proteins/immunology , T-Lymphocytes/immunology , T-Lymphocytes/parasitology
3.
Mol Immunol ; 97: 33-44, 2018 05.
Article in English | MEDLINE | ID: mdl-29558698

ABSTRACT

We report here a Leishmania donovani ornithine decarboxylase (Ld-ODC) gene used as a DNA vaccine against visceral leishmaniasis in a murine Balb/c mouse model. This study also evaluated the possible mechanism of action directed by this candidate. We found a Th1 immune response after immunization using an Ld-ODC DNA vaccine, with results based on the rearrangement of TCR-V-α-2, proliferation of Carboxy fluorescein Succinimidyle ester positive T cells, which were able to produce cytokines such as TNF-α, IFN-γ, IL-12 and IL-2, but not IL-4, IL-5, IL-6 and IL-10, and modulations of the STAT-1 and p38 MAP kinase signaling pathways. The results were corroborated with the reduction in the amastigote proliferation and parasite killing in spleens after infection in vitro. We conclude this study suggesting that the Ld-ODC DNA construct could be a new vaccine candidate against visceral leishmaniasis.


Subject(s)
Immunomodulation , Leishmania donovani/immunology , Leishmaniasis Vaccines/therapeutic use , Leishmaniasis, Visceral/prevention & control , Ornithine Decarboxylase/immunology , Vaccines, DNA/therapeutic use , Adaptive Immunity/physiology , Animals , Cells, Cultured , Disease Models, Animal , Immunization/methods , Immunomodulation/genetics , Immunomodulation/immunology , Leishmania donovani/genetics , Leishmaniasis Vaccines/immunology , Leishmaniasis, Visceral/immunology , Leishmaniasis, Visceral/pathology , Male , Mice , Mice, Inbred BALB C , Ornithine Decarboxylase/genetics , Vaccines, DNA/immunology
4.
Redox Biol ; 12: 350-366, 2017 08.
Article in English | MEDLINE | ID: mdl-28288415

ABSTRACT

Leishmania donovani is the causative organism of the neglected human disease known as visceral leishmaniasis which is often fatal, if left untreated. The cysteine biosynthesis pathway of Leishmania may serve as a potential drug target because it is different from human host and regulates downstream components of redox metabolism of the parasites; essential for their survival, pathogenicity and drug resistance. However, despite the apparent dependency of redox metabolism of cysteine biosynthesis pathway, the role of L. donovani cysteine synthase (LdCS) in drug resistance and redox homeostasis has been unexplored. Herein, we report that over-expression of LdCS in Amphotericin B (Amp B) sensitive strain (S1-OE) modulates resistance towards oxidative stress and drug pressure. We observed that antioxidant enzyme activities were up-regulated in S1-OE parasites and these parasites alleviate intracellular reactive oxygen species (ROS) efficiently by maintaining the reduced thiol pool. In contrast to S1-OE parasites, Amp B sensitive strain (S1) showed higher levels of ROS which was positively correlated with the protein carbonylation levels and negatively correlated with cell viability. Moreover, further investigations showed that LdCS over-expression also augments the ROS-primed induction of LdCS-GFP as well as endogenous LdCS and thiol pathway proteins (LdTryS, LdTryR and LdcTXN) in L. donovani parasites; which probably aids in stress tolerance and drug resistance. In addition, the expression of LdCS was found to be up-regulated in Amp B resistant isolates and during infective stationary stages of growth and consistent with these observations, our ex vivo infectivity studies confirmed that LdCS over-expression enhances the infectivity of L. donovani parasites. Our results reveal a novel crosstalk between LdCS and thiol metabolic pathway proteins and demonstrate the crucial role of LdCS in drug resistance and redox homeostasis of Leishmania.


Subject(s)
Amphotericin B/pharmacology , Cysteine Synthase/metabolism , Drug Resistance , Leishmania donovani/enzymology , Protozoan Proteins/metabolism , Sulfhydryl Compounds/metabolism , Animals , Gene Expression Regulation, Enzymologic , Humans , Leishmania donovani/drug effects , Leishmania donovani/growth & development , Mice , Oxidation-Reduction , Oxidative Stress/drug effects , Protein Carbonylation , Reactive Oxygen Species/metabolism
5.
Mol Immunol ; 82: 104-113, 2017 02.
Article in English | MEDLINE | ID: mdl-28064069

ABSTRACT

In the present study, the efficacy of Leishmania donovani protein disulfide isomerase (LdPDI) as a DNA vaccine was evaluated in BALB/C mice. Mice immunized with the LdPDI-DNA construct were found to be the most immuno-reactive, as the construct induced higher T-cell proliferation. The increased T-cell proliferation was associated with a substantial rise in Th1 and Th17+ CD4 cell response and triggered a higher proportion of CD8+ T cells for the release of interferon-gamma along with a reduced splenic parasite load on Days20 and 60 post challenge (PC). Furthermore, the vaccine construct triggered increased interferon (IFN)-γ, interleukin(IL)-17A, and IL-22 release accompanied by decreased extracellular signal-regulated kinases (ERK) 1/2 signaling and increased mitogen-activated protein kinase (MAPK) signaling coinciding with an increase in the amount of nitrite and reactive oxygen species (ROS)in vaccinating the splenocyts. We summarize from our data that the PDI-DNA construct of Leishmania donovani has the potential to elicit protective immunity through the pro-inflammatory cytokines of CD8+ and CD4+(Th1 and Th17) following an intervention in the downstream signaling event of ERK1/2 (probably through p38MAPK signaling). Therefore, the study suggests a new control against visceral leishmaniasis in the future.


Subject(s)
Leishmaniasis Vaccines/immunology , Leishmaniasis, Visceral/immunology , Protein Disulfide-Isomerases/immunology , Protozoan Proteins/immunology , Animals , Blotting, Western , Disease Models, Animal , Enzyme-Linked Immunosorbent Assay , Flow Cytometry , Leishmania donovani , Male , Mice , Mice, Inbred BALB C , Signal Transduction/immunology , Th1 Cells/immunology , Th17 Cells/immunology , Vaccines, DNA/immunology
6.
Biochimie ; 131: 29-44, 2016 Dec.
Article in English | MEDLINE | ID: mdl-27638321

ABSTRACT

Leishmania possess a unique trypanothione redox metabolism with undebated roles in protection from oxidative damage and drug resistance. The biosynthesis of trypanothione depends on l-cysteine bioavailability which is regulated by cysteine biosynthesis pathway. The de novo cysteine biosynthesis pathway is comprised of serine O-acetyltransferase (SAT) and cysteine synthase (CS) enzymes which sequentially mediate two consecutive steps of cysteine biosynthesis, and is absent in mammalian host. However, despite the apparent dependency of redox metabolism on cysteine biosynthesis pathway, the role of SAT and CS in redox homeostasis has been unexplored in Leishmania parasites. Herein, we have characterized CS and SAT to investigate their interaction and relative abundance of these proteins in promastigote vs. amastigote growth stages of L. donovani. CS and SAT genes of L. donovani (LdCS and LdSAT) were cloned, expressed, and fusion proteins purified to homogeneity with affinity column chromatography. Purified LdCS contains PLP as cofactor and showed optimum enzymatic activity at pH 7.5. Enzyme kinetics showed that LdCS catalyses the synthesis of cysteine using O-acetylserine and sulfide with a Km of 15.86 mM and 0.17 mM, respectively. Digitonin fractionation and indirect immunofluorescence microscopy showed that LdCS and LdSAT are localized in the cytoplasm of promastigotes. Size exclusion chromatography, co-purification, pull down and immuno-precipitation assays demonstrated a stable complex formation between LdCS and LdSAT proteins. Furthermore, LdCS and LdSAT proteins expression/activity was upregulated in amastigote growth stage of the parasite. Thus, the stage specific differential expression of LdCS and LdSAT suggests that it may have a role in the redox homeostasis of Leishmania.


Subject(s)
Cysteine Synthase/metabolism , Leishmania donovani/enzymology , Protozoan Proteins/metabolism , Serine O-Acetyltransferase/metabolism , Biosynthetic Pathways , Cloning, Molecular , Cysteine/biosynthesis , Cysteine Synthase/genetics , Hydrogen-Ion Concentration , Immunoblotting , Leishmania donovani/genetics , Leishmania donovani/growth & development , Life Cycle Stages , Microscopy, Fluorescence , Protein Binding , Protozoan Proteins/genetics , Serine O-Acetyltransferase/genetics , Spectrophotometry , Up-Regulation
7.
Biochimie ; 121: 312-25, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26743980

ABSTRACT

Leishmania is a unicellular protozoan parasite which causes leishmaniasis, a neglected tropical disease. It possess a unique thiol metabolism comprising of several proteins among which, tryparedoxin (cTXN) and tryparedoxin peroxidase (cTXNPx), function in concert as oxidoreductases, utilizing trypanothione as a source of electrons to reduce the hydroperoxides produced by macrophages during infection. This detoxification pathway is unique and essential for the survival of Leishmania. Herein, we report the functional characterization of Leishmania donovani cTXN and its interaction with cTXNPx. The full length recombinant cTXN and cTXNPx proteins were purified in the native state and biochemical analysis showed that the cTXN-cTXNPx coupled system efficiently degraded hydrogen peroxide and tert-butyl hydroperoxide by transferring reducing equivalents from trypanothione. In silico investigation of the potential interaction between cTXN and cTXNPx proteins showed strong interaction of model structures with amino acids Ile109, Thr132, Glu107, Trp70, Trp39, Cys40 and His129 of Ld-cTXN and Thr54, Lys93, Arg128 and Asn152 of Ld-cTXNPx predicted to be involved in interaction. Moreover, co-purification, pull down assay and immunoprecipitation studies confirmed the interaction between Ld-cTXN and Ld-cTXNPx proteins. In addition, for the first time, we demonstrated at the translational level that Ld-cTXN protein is upregulated in Amp B resistant isolates accompanied by enhanced peroxidase activity, as compared to sensitive strains. Thus, our results show that Ld-cTXN and Ld-cTXNPx proteins acts in concert by physical interaction to form a strong peroxide stress detoxification system in Leishmania and their upregulation in Amp B resistant isolates imparts better stress tolerance, and hence fitter pathogens, as compared to sensitive strains.


Subject(s)
Amphotericin B/pharmacology , Cytosol/metabolism , Leishmania donovani/drug effects , Leishmania donovani/enzymology , Peroxidases/metabolism , Protozoan Proteins/metabolism , Thioredoxins/metabolism , Animals , Antiprotozoal Agents/pharmacology , Drug Resistance , Leishmania donovani/metabolism , Male , Rabbits
8.
Biochimie ; 115: 120-35, 2015 Aug.
Article in English | MEDLINE | ID: mdl-26032732

ABSTRACT

Leishmania donovani is a unicellular protozoon parasite that causes visceral leishmaniasis (VL), which is a fatal disease if left untreated. Certain Fe-S proteins of the TCA cycle and respiratory chain have been found in the Leishmania parasite but the precise mechanisms for their biogenesis and the maturation of Fe-S clusters remains unknown. Fe-S clusters are ubiquitous cofactors of proteins that perform critical cellular functions. The clusters are biosynthesized by the mitochondrial Iron-Sulphur Cluster (ISC) machinery with core protein components that include the catalytic cysteine desulphurase IscS, the scaffold proteins IscU and IscA, and frataxin as an iron carrier/donor. However, no information regarding frataxin, its regulation, or its role in drug resistance is available for the Leishmania parasite. In this study, we characterized Ld-frataxin to investigate its role in the ISC machinery of L. donovani. We expressed and purified the recombinant Ld-frataxin protein and observed its interaction with Ld-IscU by co-purification and pull-down assay. Furthermore, we observed that the cysteine desulphurase activity of the purified Ld-IscS protein was stimulated in the presence of Ld-frataxin and Ld-IscU, particularly in the presence of iron; neither Ld-frataxin nor Ld-IscU alone had significant effects on Ld-IscS activity. Interestingly, RT-PCR and western blotting showed that Ld-frataxin is upregulated in AmpB-resistant isolates compared to sensitive strains, which may support higher Fe-S protein activity in AmpB-resistant L. donovani. Additionally, Ld-frataxin was localized in the mitochondria, as revealed by digitonin fractionation and indirect immunofluorescence. Thus, our results suggest the role of Ld-frataxin as an iron binding/carrier protein for Fe-S cluster biogenesis that physically interacts with other core components of the ISC machinery within the mitochondria.


Subject(s)
Amphotericin B/pharmacology , Drug Resistance , Iron-Binding Proteins/metabolism , Iron-Sulfur Proteins/biosynthesis , Iron-Sulfur Proteins/metabolism , Leishmania donovani/metabolism , Up-Regulation , Amino Acid Sequence , Animals , Binding Sites , Carbon-Sulfur Lyases/metabolism , Cloning, Molecular , Female , Humans , Iron/metabolism , Iron-Binding Proteins/chemistry , Iron-Binding Proteins/genetics , Iron-Binding Proteins/isolation & purification , Leishmania donovani/drug effects , Mice , Models, Molecular , Molecular Sequence Data , Phylogeny , Protein Binding , Protein Conformation , Protein Transport , Protozoan Proteins/chemistry , Protozoan Proteins/genetics , Protozoan Proteins/isolation & purification , Protozoan Proteins/metabolism , Sequence Analysis , Frataxin
9.
Cell Immunol ; 289(1-2): 76-85, 2014.
Article in English | MEDLINE | ID: mdl-24732062

ABSTRACT

In Leishmania species, protein disulfide isomerase (PDI) - a redox chaperone is primarily associated with virulence and survival. The precise mechanism, especially in relation to redox changes and its effects on immunological responses in visceral leishmaniasis (VL) is not completely understood as yet. Therefore, we purified a recombinant PDI from Leishmania donovani (r-LdPDI) which was of ∼15 kDa molecular size and examined its effects on immunological responses in peripheral blood (PBMC) of human VL cases. For these studies, alanine was tested as an inhibitor and was used in parallel to all experiments. This protein was identified to have a direct correlation with parasite growth which significantly increased number of promastigotes as well as axenic amastigotes after 96 h of culture. Our experiments examining the immunological response against r-LdPDI also indicate the activation of pro-L. donovani dictated immunological responses in VL. The stimulation of PBMC with r-LdPDI induced lactate dehydrogenase (LDH) activities and up regulated interleukin-10 (IL-10) production but not the HLA-DR expression, Nitric oxide (NO) release and IFN-γ production indicating a pivoted role for r-LdPDI in causing a strong immunosuppression in a susceptible host. Further, we observed that an addition of alanine in L. donovani culture offers a significant inhibition in growth of parasite and helps in reconstitution of protective immune response in VL cases. Therefore, we demonstrate a future cross talk on use of alanine which can reduce the activities of PDI of L. donovani, eliminating the parasite induced immunosuppression and inducing collateral host protective response in VL.


Subject(s)
Alanine/pharmacology , Leishmania donovani/enzymology , Leishmaniasis, Visceral/immunology , Protein Disulfide-Isomerases/immunology , Adolescent , Adult , Female , Humans , Immunity, Cellular/immunology , Immunologic Factors/immunology , Immunosuppression Therapy , Interferon-gamma/biosynthesis , Interleukin-10/biosynthesis , L-Lactate Dehydrogenase , Macrophages/immunology , Macrophages/parasitology , Male , Nitric Oxide/metabolism , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...